ANNEX 4 RECOMMENDATIONS ON COMPOUNDS ON THE AGENDA Acceptable Daily Intake (ADI) for human beings and other toxicological recommendations Recommended Maximum Residue Limit (MRL) Substances Anthelminthic drugs Closantel 0-0.03 mg per kg of body weight Edible tissues of sheep: 1.5 mg/kg Bovine tissues: muscle: 0.5 mg/kg1 kidney: 2 mg/kg1 liver: 1 mg/kg1 Ivermectin 0-0.0002 mg per kg of body Liver (all species): 0.015 mg/kg weight Fat (all species): 0.2 mg/kg Levamisole 0-0.003 mg per kg of body Edible tissues and milk (all weight2 species): 0.01 mg/kg1 Antimicrobial agents Benzylpenicillin 0.03 mg per person per day3 Liver, kidney, and muscle (all species): 0.05 mg/kg Milk: 0.004 mg/kg Oxytetracycline 0-0.003 mg per kg of body All species: muscle: 0.1 mg/kg weight liver: 0.3 mg/kg kidney: 0.6 mg/kg fat: 0.01 mg/kg milk: 0.1 mg/kg eggs: 0.2 mg/kg Growth promoters Carbadox Limited acceptance of Swine liver: 0.03 mg/kg5 residues4 Swine muscle: 0.005 mg/kg5 Olaquindox Limited acceptance of No MRLs allocated7 residues6 Notes to Annex 2 1. Temporary MRL (See Annex 3). 2. Temporary acdeptance (see Annexes 3 and 4). 3. Daily intake of the parent drug should be kept below this level. 4. Insufficient information was available to establish an ADI. The Committee concluded that residues resulting from the use of carbadox in pigs were acceptable provided that the recommended MRLS are not exceeded. 5. Residues are based on the levels of, and expressed as, quinoxaline-2-carboxylic acid. 6. Insufficient information was available to establish an ADI. The Committee concluded that residues resulting from the use of olaquindox in food-producing animals under conditions of good practice in the use of veterinary drugs were temporarily acceptable (see Annex 3). 7. MRLs were not established because insuficient information was available (see Annex 3).
See Also: Toxicological Abbreviations